Premium
Accuray Incorporated (ARAY)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | Mr. Sandeep ChalkeInitié | -40,00k | 15,52k | Sale to Issuer | 0,39 | 419,81k | -8,70% |
| 2026-02-28 | Mr. Leonel PeraltaInitié | 54,75k | 0,00 | Derivative Exercise and Retained Stock | - | 54,75k | - |
| 2026-02-28 | Mr. Leonel PeraltaInitié | -28,97k | 15,93k | Derivative Exercise and Sale | 0,55 | 54,75k | - |
| 2026-02-20 | Mr. Steven Francis MayerDirector | 54,88k | 30,88k | Achat | 0,56 | 1,55M | 3,68% |
| 2026-02-18 | Mr. Steven Francis MayerDirector | 195,13k | 103,80k | Achat | 0,53 | 1,49M | 15,06% |
| 2025-12-31 | Dr. Byron C. ScottInitié | 5,66k | 0,00 | Derivative Exercise and Retained Stock | - | 158,95k | 3,69% |
| 2025-12-31 | Dr. Byron C. ScottInitié | -3,77k | 3,11k | Derivative Exercise and Sale | 0,82 | 158,95k | - |
| 2025-11-29 | Mr. Sandeep ChalkeInitié | -50,31k | 51,32k | Derivative Exercise and Sale | 1,02 | 459,81k | - |
| 2025-12-01 | Mr. Sandeep ChalkeInitié | -14,16k | 14,45k | Sale to Issuer | 1,02 | 459,81k | -2,99% |
| 2025-11-29 | Mr. Ali PervaizSenior VP & CFO | -44,03k | 44,91k | Derivative Exercise and Sale | 1,02 | 352,86k | - |
| 2025-12-01 | Mr. Ali PervaizSenior VP & CFO | -13,32k | 13,58k | Sale to Issuer | 1,02 | 352,86k | -3,64% |
| 2025-11-21 | Ms. Beverly A. HussIndependent Director | 33,96k | 0,00 | Derivative Exercise and Retained Stock | - | 221,32k | 18,13% |
| 2025-11-21 | Ms. Beverly A. HussIndependent Director | -22,64k | 23,77k | Derivative Exercise and Sale | 1,05 | 221,32k | - |
| 2025-11-21 | Mr. Steven Francis MayerDirector | 45,62k | 0,00 | Derivative Exercise and Retained Stock | - | 400,23k | 12,86% |
| 2025-11-21 | Mr. Joseph E. WhittersIndependent Chairman of the Board | 56,60k | 0,00 | Derivative Exercise and Retained Stock | - | 667,66k | 9,26% |
| 2025-11-21 | Dr. Byron C. ScottInitié | 33,96k | 0,00 | Derivative Exercise and Retained Stock | - | 153,29k | 28,46% |
| 2025-11-21 | Dr. Byron C. ScottInitié | -22,64k | 23,77k | Derivative Exercise and Sale | 1,05 | 153,29k | - |
| 2025-11-21 | Mr. James M. HindmanIndependent Director | 56,60k | 0,00 | Derivative Exercise and Retained Stock | - | 294,80k | 23,76% |
| 2025-11-21 | Ms. Mika NishimuraIndependent Director | 56,60k | 0,00 | Derivative Exercise and Retained Stock | - | 212,66k | 36,27% |
| 2025-11-21 | Ms. Anne Bryce Le GrandIndependent Director | 56,60k | 0,00 | Derivative Exercise and Retained Stock | - | 259,50k | 27,90% |
| 2025-11-19 | Mr. Stephen R. LaNevePresident, CEO & Director | 20,00k | 19,41k | Achat | 0,97 | 20,00k | - |
| 2025-11-13 | Mr. Robert C.E. KillInitié | 56,60k | 0,00 | Derivative Exercise and Retained Stock | - | 162,81k | 53,30% |
| 2025-10-31 | Mr. Michael J. MurphyCorporate Controller & Principal Accounting Officer | 25,50k | 0,00 | Derivative Exercise and Retained Stock | - | 25,50k | - |
| 2025-10-31 | Mr. Michael J. MurphyCorporate Controller & Principal Accounting Officer | -12,00k | 16,92k | Derivative Exercise and Sale | 1,41 | 25,50k | - |
| 2025-06-30 | Ms. Suzanne WinterInitié | -16,73k | 22,92k | Sale to Issuer | 1,37 | 722,90k | -2,26% |
| 2025-06-13 | Mr. Joseph E. WhittersIndependent Chairman of the Board | 50,00k | 62,34k | Achat | 1,25 | 611,05k | 8,91% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
